Citadel Advisors - UTAH MED PRODS INC ownership

UTAH MED PRODS INC's ticker is UTMD and the CUSIP is 917488108. A total of 86 filers reported holding UTAH MED PRODS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of UTAH MED PRODS INC
ValueSharesWeighting
Q3 2023$396,374
-53.2%
4,609
-49.2%
0.00%
Q2 2023$846,350
-5.0%
9,081
-3.4%
0.00%
Q1 2023$891,217
+161.0%
9,404
+176.9%
0.00%
Q4 2022$341,400
+59.5%
3,396
+35.1%
0.00%
Q3 2022$214,000
-46.5%
2,513
-43.5%
0.00%
Q1 2022$400,000
+71.7%
4,451
+91.6%
0.00%
Q4 2021$233,000
+2.6%
2,323
-18.0%
0.00%
Q3 2020$227,000
-21.7%
2,833
-13.2%
0.00%
Q2 2020$290,000
-33.6%
3,265
-29.8%
0.00%
Q1 2020$437,000
+90.8%
4,648
+119.5%
0.00%
Q4 2019$229,000
-11.6%
2,118
-21.7%
0.00%
Q3 2019$259,000
+14.1%
2,704
+12.2%
0.00%
Q3 2018$227,0002,4110.00%
Other shareholders
UTAH MED PRODS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Penn Mutual Asset Management, LLC 30,283$2,822,3762.54%
Clean Yield Group 30,703$2,861,5201.18%
RICE HALL JAMES & ASSOCIATES, LLC 112,999$10,531,4680.60%
Ranger Investment Management 78,681$7,333,0690.44%
Watershed Asset Management, L.L.C. 2,515$234,3980.29%
ISTHMUS PARTNERS, LLC 20,937$1,951,3280.27%
Cardinal Capital Management 11,309$1,057,3250.21%
GLOBEFLEX CAPITAL L P 9,338$870,3020.10%
Penobscot Investment Management Company, Inc. 4,000$372,8000.06%
JAMES INVESTMENT RESEARCH INC 4,292$400,0140.05%
View complete list of UTAH MED PRODS INC shareholders